GTx

company

About

At GTx, They focus on the development of small molecules that selectively modulate the effects of certain hormones produced by the body.

  • 51 - 100

Details

Last Funding Type
Series E
Last Funding Money Raised
$20M
Industries
Biopharma,Biotechnology,Health Care
Founded date
Jan 1, 1997
Number Of Employee
51 - 100
Operating Status
Active

GTx, Inc. is a company of pioneering and driven individuals who are delivering better medicines with new science through established pathways.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$20M
GTx has raised a total of $20M in funding over 2 rounds. Their latest funding was raised on Aug 20, 2003 from a Series E round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Aug 20, 2003 Series E $20M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
GTx is funded by 1 investors. Oracle are the most recent investors.
Investor Name Lead Investor Funding Round
Oracle Series E